Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0QOI stock hub

LON/0QOI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QOIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

256.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QOI

In the news

Latest news · LON/0QOI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-23.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QOI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

EUR

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	UK
Employees	27
Employees Change	-1%
Employees Change Percent	-4.35
Enterprise value	CHF 265.1M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	IT0004147952
Last refreshed	2026-05-10
Market cap	CHF 256.9M
Price	CHF 13.51
Price currency	CHF
Rev Per Employee	617,963.11x
Sector	Healthcare
Sic	2836
Symbol	lon/0QOI
Website	https://www.newron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.5%
EV Earnings	-22.95x
EV/FCF	9.41x
EV/Sales	15.77x
FCF yield	10.97%
P/B ratio	-26.45x
P/S ratio	15.4x
PE Ratio3 Y	15.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-24.56%
EBITDA Margin	-24.45%
FCF margin	168.89%
Gross margin	100%
Gross Profit	CHF 16.7M
Gross Profit Growth	-68.06%
Gross Profit Growth Q	-84.94%
Gross Profit Growth3 Y	40%
Gross Profit Growth5 Y	16.91%
Net Income	CHF -11.5M
Net Income Growth Years	0%
Pretax Margin	-64.59%
Profit Margin	-69.22%
Profit Per Employee	CHF -427,754
ROA	-5.65
Roa5y	-5.28
ROCE	46.62
ROIC	-23.34
Roic5y	-66.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.34%
Cagr1y	64.58%
Cagr3y	42.16%
Cagr5y	43.67%
EPS Growth Years	0
Revenue Growth	-62.78x
Revenue Growth Q	-84.94x
Revenue Growth Years	0x
Revenue Growth3 Y	40x
Revenue Growth5 Y	16.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.37
Assets	CHF 34.9M
Cash	CHF 25.2M
Current Assets	CHF 32.9M
Current Liabilities	CHF 43.4M
Debt	CHF 33.3M
Debt FCF	CHF 1.18
Equity	CHF -9.7M
Interest Coverage	-1.07
Liabilities	CHF 44.7M
Long Term Assets	CHF 2M
Long Term Liabilities	CHF 1.3M
Net Cash	CHF -8.1M
Net Cash By Market Cap	CHF -3.15
Net Debt FCF	CHF 0.29
Tangible Book Value	CHF -9.7M
Tangible Book Value Per Share	CHF -0.49
WACC	8.81

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.76
Net Working Capital	CHF -2.9M
Quick ratio	0.7
Working Capital	CHF -10.5M
Working Capital Turnover	CHF 1.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-48.05%
1Y total return	64.52%
200-day SMA	15.35
3Y total return	187.39%
50-day SMA	15.97
50-day SMA vs 200-day SMA	50over200
5Y total return	511.97%
All Time High	31.85
All Time High Change	-57.59%
All Time High Date	2026-01-12
All Time Low	1.33
All Time Low Change	915.59%
All Time Low Date	2022-09-23
ATR	0.7
Beta	0.82
Ch YTD	-44.64
High	13.54
High52	31.85
High52 Date	2026-01-12
High52ch	-57.59%
Low	13.43
Low52	6.62
Low52 Date	2025-07-01
Low52ch	104.04%
Ma50ch	-15.44%
Price vs 200-day SMA	-12.03%
RSI	32.15
RSI Monthly	53.96
RSI Weekly	42.84
Sharpe ratio	1.42x
Sortino ratio	2.54
Total Return	2.98%
Tr YTD	-44.64
Tr1m	-6.96%
Tr1w	-3.41%
Tr3m	-27.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF -4.1M
Operating margin	-24.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,905,113%
Net Borrowing	-11,921,001.7
Shares Insiders	10.54%
Shares Institutions	13.25%
Shares Qo Q	0.03%
Shares Yo Y	-2.98%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 28M
Average Volume	25,206.4x
Bv Per Share	-0.49
CAPEX	CHF -41,002
Ch10y	-48.05
Ch1m	-6.95
Ch1w	-3.41
Ch1y	64.52
Ch3m	-27.56
Ch3y	187.4
Ch5y	512
Ch6m	-6.34
Change	-2.26%
Change From Open	0.5
Close	13.82
Days Gap	-2.75
Depreciation Amortization	18,165.7
Dollar Volume	40,846.3
Earnings Date	2026-09-22
EBIT	CHF -4.1M
EBITDA	CHF -4.1M
EPS	CHF -0.58
F Score	2
FCF	CHF 28.2M
FCF EV Yield	10.63x
Financing CF	-11,716,840
Fiscal Year End	December
Founded	1,999
Income Tax	CHF 772,050
Investing CF	-11,920,103
Is Primary Listing	0
Last Earnings Date	2026-03-24
Last Report Date	2025-12-31
Ma150	17.71
Ma150ch	-23.71%
Ma20	15.36
Ma20ch	-12.04%
Net CF	4,583,447
Next Earnings Date	2026-09-22
Open	13.44
P FCF Ratio	9.12
P OCF Ratio	9.1
Position In Range	70.34
Ppne	636,663.3
Price Date	2026-05-08
Relative Volume	0.12x
Revenue	16,685,004x
SBC By Revenue	1.11x
Share Based Comp	184,943
Tax By Revenue	4.63x
Tr6m	-6.34%
Volume	3,024
Z Score	1.66

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0QOI pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0QOI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QOI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.2%

Share of float held by funds and institutions

Insider ownership

+10.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-3.0%

Negative means the company is buying back shares.

Technical

LON/0QOI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.2

Neutral momentum band

Price vs 200-day MA

-12.0%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

1.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QOI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QOI stock rating?

lon/0QOI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QOI analysis?

The full report lives at /stocks/lon/0QOI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QOI?

The latest report frames lon/0QOI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QOI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.